Search Results

retropubic prostatectomy: technique and results . J Urol 1998 ; 160 : 2440 – 2445 . 2. Nelson B Kaufman M Broughton G . Comparison of length of stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy . J

cancer as an alternative to definitive therapies, such as radical prostatectomy (RP) and radiation therapy. 3 – 5 This trend of using ADT as the primary treatment choice is more pronounced among elderly patients. In an analysis based on the CaPSURE

prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases . Urol Clin North Am 2004 ; 31 : 701 – 717 . 2. Webster T Herrell SD Chang SS . Robotic

detectable PSA after radical prostatectomy (RP) in contemporary series. 1 The natural history of prostate cancer with biochemical failure after RP can be variable; however, approximately two thirds of these men will develop metastatic disease if left

The prostate cancer risk nomograms developed by Kattan et al 11 use clinical and pathologic variables to predict probability of biochemical recurrence-free progression (BCRFP) after radical prostatectomy (RP). The Kattan BCRFP nomogram (previously

Background: Historically, the incidence of prostate cancer in India and in nonresident Indians is lower than that in Western populations. Our study aims to assess complications and short-term outcomes of robotic assisted radical prostatectomy (RARP

Radical prostatectomy is the most commonly used treatment for localized prostate cancer in the United States, 1 and its popularity has been growing since the introduction of robotic-assisted prostatectomy. 2 Approximately one-third of men

explained. The NCCN Guidelines recommendation states: “Men with clinically localized disease may consider the use of tumor-based molecular assays. Retrospective case cohort studies have shown that molecular assays performed on biopsy or prostatectomy

. radical prostatectomy vs. external beam radiation vs. brachytherapy) and type of treatment (need for neurovascular bundle resection and/or pelvic lymph node dissection during radical prostatectomy) for clinically localized prostate cancer or adjuvant or

unfavorable localized disease and sufficient life expectancy to warrant definitive treatment, several randomized trials have established radical prostatectomy or radiation therapy, with or without hormonal therapy, to be a standard of care. 2 – 6 For